{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Madison",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78652",
      "recalling_firm": "ALLERGAN",
      "address_1": "1 Giralda Farms",
      "address_2": "N/A",
      "postal_code": "07940-1027",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S.A. nationwide",
      "recall_number": "D-0154-2018",
      "product_description": "Viokace (pancrelipase) tablets, 20,880 USP units, 100-count bottle, Rx only, Distributed by; Allergan USA Inc., Irvine, CA 92612, Manufactured in Canada, NDC 58914-117-10",
      "product_quantity": "12,699 bottles",
      "reason_for_recall": "Subpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile.",
      "recall_initiation_date": "20171204",
      "center_classification_date": "20180105",
      "termination_date": "20190620",
      "report_date": "20180117",
      "code_info": "Lot #: 160741A, Exp 02/18",
      "more_code_info": ""
    }
  ]
}